NASDAQ: ALMR
Alamar Biosciences Inc Stock Ownership - Who owns Alamar Biosciences?

Insider buying vs selling

Have Alamar Biosciences Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Illumina Innovation Fund II GP LLC10% Owner2026-04-20235,294$17.00
$4.00MBuy
Nicholas NaclerioDirector2026-04-20235,294$17.00
$4.00MBuy

1 of 1

ALMR insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ALMR insiders and whales buy or sell their stock.

ALMR Shareholders

What type of owners hold Alamar Biosciences Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Yuling Luo4.56%3,164,726$96.75MInsider
Qiming Corporate GP VI Ltd2.77%1,922,329$58.77MInsider
Shiping Chen1.10%760,105$23.24MInsider
Nicholas Naclerio0.74%512,762$15.68MInsider
Illumina Innovation Fund II GP LLC0.73%507,076$15.50MInsider
Timothy Ogden White0.71%491,803$15.03MInsider
Justin J. McAnear0.05%37,220$1.14MInsider
Robert P. Ragusa0.01%5,686$173.82kInsider
Sanalt0.01%4,231$129.34kInstitution
Sands Capital Alternatives LLC0.01%4,231$129.34kInstitution

1 of 3

ALMR vs Medical Device Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ALMR0.04%10.67%Net Buying
NVCR0.09%56.50%Net SellingNet Buying
ESTA0.09%18.78%Net SellingNet Buying
UFPT0.12%16.29%Net SellingNet Selling
BFLY0.06%42.45%Net SellingNet Selling

Alamar Biosciences Stock Ownership FAQ

Who owns Alamar Biosciences?

Alamar Biosciences (NASDAQ: ALMR) is owned by 0.04% institutional shareholders, 10.67% Alamar Biosciences insiders, and 89.30% retail investors. Yuling Luo is the largest individual Alamar Biosciences shareholder, owning 3.16M shares representing 4.56% of the company. Yuling Luo's Alamar Biosciences shares are currently valued at $97.47M.

If you're new to stock investing, here's how to buy Alamar Biosciences stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.